These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9871941)

  • 21. Comment: possible interaction between nefazodone and pravastatin.
    Bottorf MB
    Ann Pharmacother; 2000 Apr; 34(4):538, 541. PubMed ID: 10772447
    [No Abstract]   [Full Text] [Related]  

  • 22. Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Davis R; Whittington R; Bryson HM
    Drugs; 1997 Apr; 53(4):608-36. PubMed ID: 9098663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bupropion-SR on REM sleep: relationship to antidepressant response.
    Ott GE; Rao U; Nuccio I; Lin KM; Poland RE
    Psychopharmacology (Berl); 2002 Dec; 165(1):29-36. PubMed ID: 12474115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-year perspectives on the safety and tolerability of nefazodone.
    Dunner DL; Laird LK; Zajecka J; Bailey L; Sussman N; Seabolt JL
    J Clin Psychiatry; 2002; 63 Suppl 1():32-41. PubMed ID: 11890563
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.
    Ortega-Alvaro A; Acebes I; Saracíbar G; Echevarría E; Casis L; Micó JA
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):305-11. PubMed ID: 15138764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Haney M; Hart CL; Ward AS; Foltin RW
    Psychopharmacology (Berl); 2003 Jan; 165(2):157-65. PubMed ID: 12439626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.
    Saracíbar G; Casado A; Rodríguez VM; Portillo MP; Macarulla MT; Abecia LC; Echevarría E; Casis L
    Nutr Neurosci; 2002 Oct; 5(5):353-8. PubMed ID: 12385598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mirtazapine--pharmacologic action and clinical advantages].
    Rihmer Z; Purebl G
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):35-40. PubMed ID: 19731817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
    Rye DB; Dihenia B; Bliwise DL
    Depress Anxiety; 1998; 7(2):92-5. PubMed ID: 9614600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible penile priapism associated with nefazodone.
    Toofanny N; Maddens ME
    J Am Geriatr Soc; 2002 Sep; 50(9):1610-1. PubMed ID: 12383175
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of nefazodone on the development of experimentally induced tumors in stressed rodents.
    Freire-Garabal M; Rey-Méndez M; García-Vallejo LA; Balboa J; Suárez JM; Rodrigo E; Brenlla J; Núñez MJ
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):233-8. PubMed ID: 15164159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression.
    Göder R; Seeck-Hirschner M; Stingele K; Huchzermeier C; Kropp C; Palaschewski M; Aldenhoff J; Koch J
    J Sleep Res; 2011 Dec; 20(4):544-51. PubMed ID: 21352389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute liver failure after treatment with nefazodone.
    Lucena MI; Andrade RJ; Gomez-Outes A; Rubio M; Cabello MR
    Dig Dis Sci; 1999 Dec; 44(12):2577-9. PubMed ID: 10630516
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacokinetics of nefazodone.
    Greene DS; Barbhaiya RH
    Clin Pharmacokinet; 1997 Oct; 33(4):260-75. PubMed ID: 9342502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loratadine/nefazodone interaction.
    Barbey JT
    Clin Pharmacol Ther; 2002 May; 71(5):403; author reply 403. PubMed ID: 12011827
    [No Abstract]   [Full Text] [Related]  

  • 38. Nefazodone in primary insomnia: an open pilot study.
    Wiegand MH; Galanakis P; Schreiner R
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis.
    Karnik NS; Maldonado JR
    Psychosomatics; 2005; 46(6):565-8. PubMed ID: 16288136
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response.
    Ott GE; Rao U; Lin KM; Gertsik L; Poland RE
    Int J Neuropsychopharmacol; 2004 Sep; 7(3):275-81. PubMed ID: 15122973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.